Dosage & AdministrationDrug labelPrior authorizationFinancial assistance
Patient educationPeople also ask

Ajovy

(fremanezumab)
AJOVY 225 MG in 1.5 mL Auto-InjectorAJOVY 225 MG in 1.5 mL Prefilled Syringe
NO BLACK BOX WARNING

Dosage & administration

drug label

Ajovy prescribing information

Contact Medical Science LiaisonReport Adverse Event

prior authorization

Ajovy prior authorization resources

Most recent Ajovy prior authorization forms

View By Payer
Verified: Sep 10, 2023Kaiser Permanente - Mid-Atlantic Ajovy Prior Authorization Form Mid-Atlantic States
Verified: Sep 04, 2023Highmark BCBS Northeastern NY - CGRP Inhibitors Prior Authorization Form
Verified: Sep 04, 2023Highmark BCBS Western NY - CGRP Inhibitors Prior Authorization Form
Verified: Oct 03, 2023Highmark West Virginia - CGRP Inhibitors Prior Authorization Form
Verified: Oct 03, 2023Highmark BCBS Delaware - CGRP Inhibitors Prior Authorization Form
Verified: Oct 03, 2023Highmark BCBS Central PA - CGRP Inhibitors Prior Authorization Form
Verified: Oct 02, 2023Highmark BCBS Western PA - CGRP Inhibitors Prior Authorization Form
Verified: Sep 29, 2023Johns Hopkins Healthcare - Ajovy Prior Authorization Form
Verified: Sep 29, 2023Sooner Care - Ajovy Prior Authorization Form
Verified: Sep 28, 2023Keystone First - Migraine Prevention Agents Prior Authorization Form

PDFComplete Letter of Medical Necessity
Coverage Authorization Request

PDFCoverage Authorization Appeals
Learn More

financial assistance

Ajovy financial assistance options

Co-pay savings program

commercial only
Enroll in Patient Savings Program
Learn More

Foundation programs

under insured
no insurance
goverment insurance
65+
Teva Patient Assistance Program
Learn More

patient education

Ajovy patient education

Getting started on Ajovy

BRAND PAGEInstructions For Use (Prefilled Syringe) : Migraine Prevention
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

BRAND PAGEInstructions For Use (Prefilled Autoinjector): Migraine Prevention
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
To share resource; ask patient to:
1.Pull out phone
2.Open camera
3.Scan QR code with camera
4.Tap link

Patient toolkit

BRAND PAGEAbout Ajovy
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

BRAND PAGESide Effects
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

OTHERView How to Take Ajovy
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

VIDEOPatient Stories
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

OTHERPatient Resources: Patients Considering Ajovy
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

OTHERPatient Resources: Patients On Ajovy
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

PDFDoctor Discussion Guide: Patients Considering Ajovy
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

PDFMigraine Tracker
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Learn More

Other resources

Sharps Container
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Learn More

people also ask

Ajovy FAQs

Is there a pregnancy exposure registry for AJOVY?Yes, there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to AJOVY during pregnancy. Healthcare providers are encouraged to register pregnant patients, or pregnant women may enroll themselves in the registry by calling 1-833-927-2605 or visiting www.tevamigrainepregnancyregistry.com.
What is the risk associated with the use of AJOVY during pregnancy?There are no adequate data on the developmental risk associated with the use of AJOVY in pregnant women. AJOVY has a long half-life, which should be taken into consideration for women who are pregnant or plan to become pregnant while using AJOVY. However, administration of fremanezumab-vfrm (the active ingredient in AJOVY) to rats and rabbits during the period of organogenesis or to rats throughout pregnancy and lactation at doses resulting in plasma levels greater than those expected clinically did not result in adverse effects on development.
What is the estimated background risk of major birth defects and miscarriage for the indicated population?The estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2-4% and 15-20%, respectively, for the U.S. general population. The estimated rate of major birth defects and miscarriage among deliveries to women with migraine are similar to rates reported in women without migraine.
Is AJOVY safe to use during lactation?There are no data on the presence of fremanezumab-vfrm (the active ingredient in AJOVY) in human milk, the effects on the breastfed infant, or the effects on milk production. The developmental and health benefits of breastfeeding should be considered along with the mother's clinical need for AJOVY and any potential adverse effects on the breastfed infant from AJOVY or from the underlying maternal condition.
Is AJOVY safe and effective for use in pediatric patients?Safety and effectiveness in pediatric patients have not been established.
Is there any information on the use of AJOVY in geriatric patients?Clinical studies of AJOVY did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects.
FAQ Data Source